BioMarin Pharmaceutical
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has BioMarin Pharmaceutical's balance sheet done over the years? Its assets were worth $6,841,603,000 last year, which is more than in the previous period. 28% of BioMarin Pharmaceutical’s total assets is currently financed by debt. Its liabilities reached the amount of $1,890,054,000, which means an increase by 7% compared compared to last year.
Debt to Assets
| 2014 | 2490453000 | 962.55M | 38.65% |
|---|---|---|---|
| 2015 | 3729368000 | 1.32B | 35.62% |
| 2016 | 4023690000 | 1.25B | 31.25% |
| 2017 | 4633125000 | 1.82B | 39.38% |
| 2018 | 4427128000 | 1.45B | 32.96% |
| 2019 | 4690039000 | 1.56B | 33.43% |
| 2020 | 5848020000 | 1.74B | 29.79% |
| 2021 | 6003325000 | 1.73B | 28.86% |
| 2022 | 6375074000 | 1.77B | 27.79% |
| 2023 | 6841603000 | 1.89B | 27.63% |
BMRN Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 755.12M | 724.53M | 587.27M | 649.15M | 437.44M | 493.98M | 598.02M | 408.33M | 397.04M | 875.48M |
Short term investments | 318.68M | 567.00M | 426.59M | 416.22M | 316.36M | 590.32M | 797.94M | 381.34M | 195.57M | 69.70M |
Net receivables | 633.70M | 461.31M | 373.39M | 448.35M | 377.40M | 342.63M | 261.36M | 215.28M | 164.95M | 144.47M |
Inventory | 1.10B | 894.08M | 776.66M | 698.54M | 680.27M | 530.87M | 475.77M | 355.12M | 271.68M | 199.45M |
Other current assets | 141.39M | 104.52M | 110.44M | 129.93M | 130.65M | 98.40M | 74.03M | 61.70M | 60.37M | 140.7M |
Total current assets | 2.95B | 2.75B | 2.27B | 2.34B | 1.94B | 2.05B | 2.20B | 1.42B | 1.08B | 1.42B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 1.11B | 1.07B | 1.03B | 1.03B | 1.01B | 948.68M | 896.7M | 798.76M | 704.20M | 523.51M |
Goodwill | 196.19M | 196.19M | 196.19M | 196.19M | 197.03M | 197.03M | 197.03M | 197.03M | 197.03M | 54.25M |
Intangible assets | 294.70M | 338.56M | 388.65M | 417.27M | 456.58M | 491.80M | 517.51M | 553.78M | 683.99M | 156.57M |
Long term investments | 611.13M | 333.83M | 507.79M | 285.47M | 411.97M | 235.86M | 385.78M | 572.71M | 425.65M | 98.89M |
Other non-current assets | 125.46M | 176.23M | 151.76M | 142.23M | 122.00M | 36.56M | 29.85M | 32.81M | 408.64M | 65.28M |
Total non-current assets | 3.88B | 3.62B | 3.72B | 3.50B | 2.74B | 2.37B | 2.42B | 2.60B | 2.63B | 1.06B |
Total assets | 6.84B | 6.37B | 6.00B | 5.84B | 4.69B | 4.42B | 4.63B | 4.02B | 3.72B | 2.49B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 4.62M | 711K | 6.95M | 152K | 13.03M | 0 | 0 | 0 | 0 | 0 |
Short term debt | 502.65M | 10.37M | 10.46M | 11.75M | 361.88M | 0 | 360.94M | 22.47M | 0 | 0 |
Total current liabilities | 1.17B | 588.88M | 539.82M | 492.54M | 932.50M | 523.24M | 816.51M | 439.31M | 445.45M | 235.73M |
| Non-current liabilities: | ||||||||||
Long term debt | 593.09M | 1.08B | 1.07B | 1.07B | 486.23M | 830.41M | 813.52M | 660.76M | 662.28M | 657.97M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 119.93M | 100.01M | 113.68M | 174.32M | 148.91M | 105.53M | 194.42M | 157.34M | 77.25M | 68.84M |
Total non-current liabilities | 713.03M | 1.18B | 1.19B | 1.24B | 635.15M | 935.94M | 1.00B | 818.10M | 883.06M | 726.82M |
Total liabilities | 1.89B | 1.77B | 1.73B | 1.74B | 1.56B | 1.45B | 1.82B | 1.25B | 1.32B | 962.55M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |